Gopal, Srila <br/><br/>
A phosphoproteomic signature in endothelial cells predicts vascular toxicity of tyrosine kinase inhibitors used in CML.  [electronic resource] 

 -  Blood advances  07 2018 
 - 1680-1684 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>2473-9537 
<br/><br/><label>Standard No.: </label>10.1182/bloodadvances.2018020396  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aniline Compounds--adverse effects<br/>Human Umbilical Vein Endothelial Cells--metabolism<br/>Humans<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Nitriles--adverse effects<br/>Phosphoproteins--metabolism<br/>Protein Kinase Inhibitors--adverse effects<br/>Proteomics<br/>Quinolines--adverse effects